Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn's disease: application of L émann Index.

Conclusion: Treatment with adalimumab halts the progression of bowel damage in CD while that with azathioprine does not. PMID: 31692395 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research